http://rezul.com/news/10330498

Global Private Group has advised Biopharmaceutical Company on the raising of EUR 270 million through a placing of new shares Global Private Group acted as reporting accountant on the fund raising, and sole arranger. NEW YORK - May 2, 2017 - Rezul -- Global Private Group has advised Biopharmaceutical Company on the raising of EUR 270 million through a placing of new shares. Global Private Group acted as reporting accountant on the fund raising, and sole arranger. The Biopharmaceutical Company is a life sciences company providing services and technologies enabling the development and manufacture of biopharmaceutical products. Since its admission the business has grown significantly organically and via acquisition in both the Europe and US. The Biopharmaceutical Company intends to use the proceeds from the placing to acquire a Chemistry Research Solutions Company, a specialist contract chemistry and bio-conjugation company with operations in Europe and US, and to back further research and development work.